nodes	percent_of_prediction	percent_of_DWPC	metapath
Venlafaxine—ABCG2—Vandetanib—thyroid cancer	0.155	0.235	CbGbCtD
Venlafaxine—ABCG2—Sorafenib—thyroid cancer	0.0932	0.142	CbGbCtD
Venlafaxine—CYP2B6—Sorafenib—thyroid cancer	0.0656	0.0998	CbGbCtD
Venlafaxine—ABCG2—Doxorubicin—thyroid cancer	0.0566	0.0861	CbGbCtD
Venlafaxine—CYP2C19—Sorafenib—thyroid cancer	0.0417	0.0634	CbGbCtD
Venlafaxine—CYP2B6—Doxorubicin—thyroid cancer	0.0398	0.0606	CbGbCtD
Venlafaxine—CYP2C9—Sorafenib—thyroid cancer	0.0346	0.0527	CbGbCtD
Venlafaxine—ABCB1—Sorafenib—thyroid cancer	0.0336	0.0512	CbGbCtD
Venlafaxine—CYP3A4—Vandetanib—thyroid cancer	0.0334	0.0509	CbGbCtD
Venlafaxine—CYP2D6—Sorafenib—thyroid cancer	0.0317	0.0482	CbGbCtD
Venlafaxine—ABCB1—Doxorubicin—thyroid cancer	0.0204	0.0311	CbGbCtD
Venlafaxine—CYP3A4—Sorafenib—thyroid cancer	0.0201	0.0307	CbGbCtD
Venlafaxine—CYP2D6—Doxorubicin—thyroid cancer	0.0192	0.0293	CbGbCtD
Venlafaxine—CYP3A4—Doxorubicin—thyroid cancer	0.0122	0.0186	CbGbCtD
Venlafaxine—SLC6A3—Dopaminergic Neurogenesis—RET—thyroid cancer	0.00116	0.0416	CbGpPWpGaD
Venlafaxine—CYP2B6—Liver X Receptor Pathway—RXRA—thyroid cancer	0.000741	0.0267	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—CALCB—thyroid cancer	0.000613	0.022	CbGpPWpGaD
Venlafaxine—ABCG2—Iron uptake and transport—CP—thyroid cancer	0.0005	0.018	CbGpPWpGaD
Venlafaxine—ABCG2—HIF-2-alpha transcription factor network—EPO—thyroid cancer	0.000474	0.017	CbGpPWpGaD
Venlafaxine—ABCG2—Fluoropyrimidine Activity—SMUG1—thyroid cancer	0.000433	0.0156	CbGpPWpGaD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—SST—thyroid cancer	0.000432	0.0155	CbGpPWpGaD
Venlafaxine—CYP2C19—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000428	0.0154	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—RET—thyroid cancer	0.000406	0.0146	CbGpPWpGaD
Venlafaxine—CYP2C9—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00039	0.014	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.000377	0.0136	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	0.000373	0.0134	CbGpPWpGaD
Venlafaxine—NPY1R—G alpha (i) signalling events—SST—thyroid cancer	0.000364	0.0131	CbGpPWpGaD
Venlafaxine—ABCG2—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.000355	0.0128	CbGpPWpGaD
Venlafaxine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	0.000354	0.0127	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—CALCB—thyroid cancer	0.000346	0.0125	CbGpPWpGaD
Venlafaxine—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.000337	0.0121	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—NKX2-1—thyroid cancer	0.000323	0.0116	CbGpPWpGaD
Venlafaxine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—thyroid cancer	0.000321	0.0115	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—CALCB—thyroid cancer	0.000314	0.0113	CbGpPWpGaD
Venlafaxine—CYP2B6—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000292	0.0105	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.00029	0.0104	CbGpPWpGaD
Venlafaxine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—thyroid cancer	0.000284	0.0102	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—TSHR—thyroid cancer	0.000284	0.0102	CbGpPWpGaD
Venlafaxine—ABCG2—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.000279	0.01	CbGpPWpGaD
Venlafaxine—CYP2B6—Metapathway biotransformation—CHST14—thyroid cancer	0.000258	0.00927	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.000251	0.00902	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—PTCH1—thyroid cancer	0.000241	0.00868	CbGpPWpGaD
Venlafaxine—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000221	0.00794	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—SST—thyroid cancer	0.000221	0.00793	CbGpPWpGaD
Venlafaxine—Ataxia—Epirubicin—thyroid cancer	0.000218	0.000691	CcSEcCtD
Venlafaxine—Blood creatinine increased—Epirubicin—thyroid cancer	0.000217	0.000689	CcSEcCtD
Venlafaxine—Dehydration—Epirubicin—thyroid cancer	0.000216	0.000684	CcSEcCtD
Venlafaxine—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000216	0.00775	CbGpPWpGaD
Venlafaxine—Hyponatraemia—Doxorubicin—thyroid cancer	0.000215	0.000683	CcSEcCtD
Venlafaxine—Diplopia—Doxorubicin—thyroid cancer	0.000215	0.00068	CcSEcCtD
Venlafaxine—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000215	0.00068	CcSEcCtD
Venlafaxine—Osteoarthritis—Doxorubicin—thyroid cancer	0.000215	0.00068	CcSEcCtD
Venlafaxine—Liver function test abnormal—Epirubicin—thyroid cancer	0.000214	0.000679	CcSEcCtD
Venlafaxine—Dry skin—Epirubicin—thyroid cancer	0.000213	0.000674	CcSEcCtD
Venlafaxine—NPY1R—GPCR ligand binding—CALCA—thyroid cancer	0.000212	0.00764	CbGpPWpGaD
Venlafaxine—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000212	0.000672	CcSEcCtD
Venlafaxine—Affect lability—Doxorubicin—thyroid cancer	0.000211	0.00067	CcSEcCtD
Venlafaxine—Migraine—Doxorubicin—thyroid cancer	0.000211	0.00067	CcSEcCtD
Venlafaxine—Hypokalaemia—Epirubicin—thyroid cancer	0.000211	0.000669	CcSEcCtD
Venlafaxine—Diarrhoea—Sorafenib—thyroid cancer	0.000211	0.000669	CcSEcCtD
Venlafaxine—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000209	0.000662	CcSEcCtD
Venlafaxine—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000209	0.000662	CcSEcCtD
Venlafaxine—Face oedema—Doxorubicin—thyroid cancer	0.000207	0.000657	CcSEcCtD
Venlafaxine—Gastritis—Epirubicin—thyroid cancer	0.000205	0.000651	CcSEcCtD
Venlafaxine—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000205	0.000649	CcSEcCtD
Venlafaxine—Muscular weakness—Epirubicin—thyroid cancer	0.000205	0.000649	CcSEcCtD
Venlafaxine—Cardiac arrest—Doxorubicin—thyroid cancer	0.000204	0.000647	CcSEcCtD
Venlafaxine—Dizziness—Sorafenib—thyroid cancer	0.000204	0.000647	CcSEcCtD
Venlafaxine—Mood swings—Doxorubicin—thyroid cancer	0.000203	0.000645	CcSEcCtD
Venlafaxine—Abdominal distension—Epirubicin—thyroid cancer	0.000202	0.00064	CcSEcCtD
Venlafaxine—Ataxia—Doxorubicin—thyroid cancer	0.000202	0.00064	CcSEcCtD
Venlafaxine—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.000202	0.00725	CbGpPWpGaD
Venlafaxine—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000201	0.00724	CbGpPWpGaD
Venlafaxine—SLC6A4—NRF2 pathway—SLC5A5—thyroid cancer	0.000201	0.00724	CbGpPWpGaD
Venlafaxine—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000201	0.000637	CcSEcCtD
Venlafaxine—Asthma—Epirubicin—thyroid cancer	0.0002	0.000636	CcSEcCtD
Venlafaxine—Influenza—Epirubicin—thyroid cancer	0.0002	0.000636	CcSEcCtD
Venlafaxine—Dysphagia—Epirubicin—thyroid cancer	0.0002	0.000636	CcSEcCtD
Venlafaxine—Dehydration—Doxorubicin—thyroid cancer	0.0002	0.000633	CcSEcCtD
Venlafaxine—Eosinophilia—Epirubicin—thyroid cancer	0.000198	0.000629	CcSEcCtD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—SST—thyroid cancer	0.000198	0.00713	CbGpPWpGaD
Venlafaxine—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000198	0.000628	CcSEcCtD
Venlafaxine—Dry skin—Doxorubicin—thyroid cancer	0.000197	0.000624	CcSEcCtD
Venlafaxine—Pancreatitis—Epirubicin—thyroid cancer	0.000197	0.000623	CcSEcCtD
Venlafaxine—Vomiting—Sorafenib—thyroid cancer	0.000196	0.000622	CcSEcCtD
Venlafaxine—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000196	0.000621	CcSEcCtD
Venlafaxine—Hypokalaemia—Doxorubicin—thyroid cancer	0.000195	0.000619	CcSEcCtD
Venlafaxine—Angina pectoris—Epirubicin—thyroid cancer	0.000195	0.000619	CcSEcCtD
Venlafaxine—CYP2C19—Metapathway biotransformation—CHST14—thyroid cancer	0.000195	0.00701	CbGpPWpGaD
Venlafaxine—Rash—Sorafenib—thyroid cancer	0.000194	0.000617	CcSEcCtD
Venlafaxine—Dermatitis—Sorafenib—thyroid cancer	0.000194	0.000616	CcSEcCtD
Venlafaxine—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000193	0.000613	CcSEcCtD
Venlafaxine—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000193	0.000613	CcSEcCtD
Venlafaxine—Headache—Sorafenib—thyroid cancer	0.000193	0.000613	CcSEcCtD
Venlafaxine—Bronchitis—Epirubicin—thyroid cancer	0.000193	0.000611	CcSEcCtD
Venlafaxine—ABCB1—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.000192	0.00691	CbGpPWpGaD
Venlafaxine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	0.000191	0.00688	CbGpPWpGaD
Venlafaxine—Pancytopenia—Epirubicin—thyroid cancer	0.00019	0.000604	CcSEcCtD
Venlafaxine—Gastritis—Doxorubicin—thyroid cancer	0.00019	0.000602	CcSEcCtD
Venlafaxine—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000189	0.0006	CcSEcCtD
Venlafaxine—Muscular weakness—Doxorubicin—thyroid cancer	0.000189	0.0006	CcSEcCtD
Venlafaxine—Dysuria—Epirubicin—thyroid cancer	0.000187	0.000594	CcSEcCtD
Venlafaxine—Neutropenia—Epirubicin—thyroid cancer	0.000187	0.000594	CcSEcCtD
Venlafaxine—Abdominal distension—Doxorubicin—thyroid cancer	0.000187	0.000592	CcSEcCtD
Venlafaxine—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000186	0.000591	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—CALCB—thyroid cancer	0.000186	0.00668	CbGpPWpGaD
Venlafaxine—Dysphagia—Doxorubicin—thyroid cancer	0.000185	0.000588	CcSEcCtD
Venlafaxine—Influenza—Doxorubicin—thyroid cancer	0.000185	0.000588	CcSEcCtD
Venlafaxine—Asthma—Doxorubicin—thyroid cancer	0.000185	0.000588	CcSEcCtD
Venlafaxine—Pollakiuria—Epirubicin—thyroid cancer	0.000185	0.000587	CcSEcCtD
Venlafaxine—Eosinophilia—Doxorubicin—thyroid cancer	0.000184	0.000582	CcSEcCtD
Venlafaxine—Nausea—Sorafenib—thyroid cancer	0.000183	0.000581	CcSEcCtD
Venlafaxine—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000183	0.00058	CcSEcCtD
Venlafaxine—Weight increased—Epirubicin—thyroid cancer	0.000182	0.000578	CcSEcCtD
Venlafaxine—Pancreatitis—Doxorubicin—thyroid cancer	0.000182	0.000577	CcSEcCtD
Venlafaxine—Weight decreased—Epirubicin—thyroid cancer	0.000181	0.000575	CcSEcCtD
Venlafaxine—Hyperglycaemia—Epirubicin—thyroid cancer	0.000181	0.000573	CcSEcCtD
Venlafaxine—Angina pectoris—Doxorubicin—thyroid cancer	0.000181	0.000573	CcSEcCtD
Venlafaxine—Pneumonia—Epirubicin—thyroid cancer	0.00018	0.00057	CcSEcCtD
Venlafaxine—CYP2D6—Metapathway biotransformation—CHST14—thyroid cancer	0.000179	0.00644	CbGpPWpGaD
Venlafaxine—Bronchitis—Doxorubicin—thyroid cancer	0.000178	0.000566	CcSEcCtD
Venlafaxine—CYP2C9—Metapathway biotransformation—CHST14—thyroid cancer	0.000178	0.00639	CbGpPWpGaD
Venlafaxine—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000177	0.000562	CcSEcCtD
Venlafaxine—CYP2B6—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000177	0.00636	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—TRIM33—thyroid cancer	0.000176	0.00633	CbGpPWpGaD
Venlafaxine—Pancytopenia—Doxorubicin—thyroid cancer	0.000176	0.000558	CcSEcCtD
Venlafaxine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000176	0.00632	CbGpPWpGaD
Venlafaxine—Renal failure—Epirubicin—thyroid cancer	0.000176	0.000557	CcSEcCtD
Venlafaxine—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000175	0.000555	CcSEcCtD
Venlafaxine—Stomatitis—Epirubicin—thyroid cancer	0.000174	0.000552	CcSEcCtD
Venlafaxine—Jaundice—Epirubicin—thyroid cancer	0.000174	0.000552	CcSEcCtD
Venlafaxine—Conjunctivitis—Epirubicin—thyroid cancer	0.000174	0.000551	CcSEcCtD
Venlafaxine—ABCG2—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.000173	0.00624	CbGpPWpGaD
Venlafaxine—Neutropenia—Doxorubicin—thyroid cancer	0.000173	0.00055	CcSEcCtD
Venlafaxine—Dysuria—Doxorubicin—thyroid cancer	0.000173	0.00055	CcSEcCtD
Venlafaxine—SLC6A2—NRF2 pathway—SLC5A5—thyroid cancer	0.000173	0.00622	CbGpPWpGaD
Venlafaxine—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000172	0.000547	CcSEcCtD
Venlafaxine—Sweating—Epirubicin—thyroid cancer	0.000171	0.000543	CcSEcCtD
Venlafaxine—Pollakiuria—Doxorubicin—thyroid cancer	0.000171	0.000543	CcSEcCtD
Venlafaxine—Haematuria—Epirubicin—thyroid cancer	0.00017	0.00054	CcSEcCtD
Venlafaxine—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000169	0.000537	CcSEcCtD
Venlafaxine—SLC6A4—NRF2 pathway—RXRA—thyroid cancer	0.000169	0.00608	CbGpPWpGaD
Venlafaxine—Weight increased—Doxorubicin—thyroid cancer	0.000169	0.000535	CcSEcCtD
Venlafaxine—Epistaxis—Epirubicin—thyroid cancer	0.000169	0.000535	CcSEcCtD
Venlafaxine—Weight decreased—Doxorubicin—thyroid cancer	0.000168	0.000532	CcSEcCtD
Venlafaxine—Sinusitis—Epirubicin—thyroid cancer	0.000168	0.000532	CcSEcCtD
Venlafaxine—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000167	0.00053	CcSEcCtD
Venlafaxine—Agranulocytosis—Epirubicin—thyroid cancer	0.000167	0.000529	CcSEcCtD
Venlafaxine—Pneumonia—Doxorubicin—thyroid cancer	0.000166	0.000527	CcSEcCtD
Venlafaxine—ABCG2—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.000166	0.00597	CbGpPWpGaD
Venlafaxine—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000164	0.00052	CcSEcCtD
Venlafaxine—Bradycardia—Epirubicin—thyroid cancer	0.000163	0.000518	CcSEcCtD
Venlafaxine—Renal failure—Doxorubicin—thyroid cancer	0.000163	0.000515	CcSEcCtD
Venlafaxine—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000162	0.000514	CcSEcCtD
Venlafaxine—Haemoglobin—Epirubicin—thyroid cancer	0.000161	0.000511	CcSEcCtD
Venlafaxine—Jaundice—Doxorubicin—thyroid cancer	0.000161	0.000511	CcSEcCtD
Venlafaxine—Stomatitis—Doxorubicin—thyroid cancer	0.000161	0.000511	CcSEcCtD
Venlafaxine—Rhinitis—Epirubicin—thyroid cancer	0.000161	0.00051	CcSEcCtD
Venlafaxine—Conjunctivitis—Doxorubicin—thyroid cancer	0.000161	0.00051	CcSEcCtD
Venlafaxine—Hepatitis—Epirubicin—thyroid cancer	0.00016	0.000509	CcSEcCtD
Venlafaxine—Haemorrhage—Epirubicin—thyroid cancer	0.00016	0.000509	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—TSHR—thyroid cancer	0.00016	0.00577	CbGpPWpGaD
Venlafaxine—Hypoaesthesia—Epirubicin—thyroid cancer	0.00016	0.000506	CcSEcCtD
Venlafaxine—Pharyngitis—Epirubicin—thyroid cancer	0.000159	0.000505	CcSEcCtD
Venlafaxine—Sweating—Doxorubicin—thyroid cancer	0.000159	0.000503	CcSEcCtD
Venlafaxine—Haematuria—Doxorubicin—thyroid cancer	0.000158	0.0005	CcSEcCtD
Venlafaxine—Epistaxis—Doxorubicin—thyroid cancer	0.000156	0.000495	CcSEcCtD
Venlafaxine—Sinusitis—Doxorubicin—thyroid cancer	0.000155	0.000492	CcSEcCtD
Venlafaxine—Visual impairment—Epirubicin—thyroid cancer	0.000155	0.00049	CcSEcCtD
Venlafaxine—Agranulocytosis—Doxorubicin—thyroid cancer	0.000154	0.000489	CcSEcCtD
Venlafaxine—SLC6A3—NRF2 pathway—SLC5A5—thyroid cancer	0.000153	0.00551	CbGpPWpGaD
Venlafaxine—Erythema multiforme—Epirubicin—thyroid cancer	0.000152	0.000481	CcSEcCtD
Venlafaxine—Bradycardia—Doxorubicin—thyroid cancer	0.000151	0.000479	CcSEcCtD
Venlafaxine—ABCB1—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.000151	0.00542	CbGpPWpGaD
Venlafaxine—Tinnitus—Epirubicin—thyroid cancer	0.00015	0.000474	CcSEcCtD
Venlafaxine—Haemoglobin—Doxorubicin—thyroid cancer	0.000149	0.000473	CcSEcCtD
Venlafaxine—Cardiac disorder—Epirubicin—thyroid cancer	0.000149	0.000472	CcSEcCtD
Venlafaxine—Flushing—Epirubicin—thyroid cancer	0.000149	0.000472	CcSEcCtD
Venlafaxine—Rhinitis—Doxorubicin—thyroid cancer	0.000149	0.000472	CcSEcCtD
Venlafaxine—Haemorrhage—Doxorubicin—thyroid cancer	0.000148	0.000471	CcSEcCtD
Venlafaxine—Hepatitis—Doxorubicin—thyroid cancer	0.000148	0.000471	CcSEcCtD
Venlafaxine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000148	0.000468	CcSEcCtD
Venlafaxine—Pharyngitis—Doxorubicin—thyroid cancer	0.000147	0.000467	CcSEcCtD
Venlafaxine—SLC6A4—NRF2 pathway—NRG1—thyroid cancer	0.000146	0.00526	CbGpPWpGaD
Venlafaxine—SLC6A2—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000146	0.00524	CbGpPWpGaD
Venlafaxine—SLC6A2—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000146	0.00524	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—TSHR—thyroid cancer	0.000146	0.00524	CbGpPWpGaD
Venlafaxine—SLC6A2—NRF2 pathway—RXRA—thyroid cancer	0.000145	0.00523	CbGpPWpGaD
Venlafaxine—Chills—Epirubicin—thyroid cancer	0.000144	0.000456	CcSEcCtD
Venlafaxine—Arrhythmia—Epirubicin—thyroid cancer	0.000143	0.000454	CcSEcCtD
Venlafaxine—CYP2B6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000143	0.00515	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000143	0.00515	CbGpPWpGaD
Venlafaxine—Visual impairment—Doxorubicin—thyroid cancer	0.000143	0.000454	CcSEcCtD
Venlafaxine—Alopecia—Epirubicin—thyroid cancer	0.000142	0.00045	CcSEcCtD
Venlafaxine—Erythema multiforme—Doxorubicin—thyroid cancer	0.00014	0.000445	CcSEcCtD
Venlafaxine—Erythema—Epirubicin—thyroid cancer	0.00014	0.000443	CcSEcCtD
Venlafaxine—Tinnitus—Doxorubicin—thyroid cancer	0.000138	0.000439	CcSEcCtD
Venlafaxine—Flushing—Doxorubicin—thyroid cancer	0.000138	0.000437	CcSEcCtD
Venlafaxine—Cardiac disorder—Doxorubicin—thyroid cancer	0.000138	0.000437	CcSEcCtD
Venlafaxine—Flatulence—Epirubicin—thyroid cancer	0.000138	0.000436	CcSEcCtD
Venlafaxine—Tension—Epirubicin—thyroid cancer	0.000137	0.000435	CcSEcCtD
Venlafaxine—Dysgeusia—Epirubicin—thyroid cancer	0.000137	0.000434	CcSEcCtD
Venlafaxine—Nervousness—Epirubicin—thyroid cancer	0.000136	0.00043	CcSEcCtD
Venlafaxine—Back pain—Epirubicin—thyroid cancer	0.000135	0.000428	CcSEcCtD
Venlafaxine—Muscle spasms—Epirubicin—thyroid cancer	0.000134	0.000426	CcSEcCtD
Venlafaxine—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000134	0.0048	CbGpPWpGaD
Venlafaxine—Chills—Doxorubicin—thyroid cancer	0.000133	0.000422	CcSEcCtD
Venlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000133	0.00478	CbGpPWpGaD
Venlafaxine—Arrhythmia—Doxorubicin—thyroid cancer	0.000133	0.00042	CcSEcCtD
Venlafaxine—Vision blurred—Epirubicin—thyroid cancer	0.000132	0.000417	CcSEcCtD
Venlafaxine—Alopecia—Doxorubicin—thyroid cancer	0.000131	0.000416	CcSEcCtD
Venlafaxine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.00013	0.00466	CbGpPWpGaD
Venlafaxine—Ill-defined disorder—Epirubicin—thyroid cancer	0.00013	0.000411	CcSEcCtD
Venlafaxine—Erythema—Doxorubicin—thyroid cancer	0.000129	0.00041	CcSEcCtD
Venlafaxine—Anaemia—Epirubicin—thyroid cancer	0.000129	0.000409	CcSEcCtD
Venlafaxine—SLC6A3—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000129	0.00464	CbGpPWpGaD
Venlafaxine—SLC6A3—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000129	0.00464	CbGpPWpGaD
Venlafaxine—SLC6A3—NRF2 pathway—RXRA—thyroid cancer	0.000129	0.00463	CbGpPWpGaD
Venlafaxine—Agitation—Epirubicin—thyroid cancer	0.000128	0.000407	CcSEcCtD
Venlafaxine—Flatulence—Doxorubicin—thyroid cancer	0.000127	0.000404	CcSEcCtD
Venlafaxine—Tension—Doxorubicin—thyroid cancer	0.000127	0.000402	CcSEcCtD
Venlafaxine—Dysgeusia—Doxorubicin—thyroid cancer	0.000127	0.000401	CcSEcCtD
Venlafaxine—Malaise—Epirubicin—thyroid cancer	0.000126	0.000399	CcSEcCtD
Venlafaxine—SLC6A2—NRF2 pathway—NRG1—thyroid cancer	0.000126	0.00452	CbGpPWpGaD
Venlafaxine—Nervousness—Doxorubicin—thyroid cancer	0.000126	0.000398	CcSEcCtD
Venlafaxine—Vertigo—Epirubicin—thyroid cancer	0.000125	0.000398	CcSEcCtD
Venlafaxine—Syncope—Epirubicin—thyroid cancer	0.000125	0.000397	CcSEcCtD
Venlafaxine—Leukopenia—Epirubicin—thyroid cancer	0.000125	0.000396	CcSEcCtD
Venlafaxine—Back pain—Doxorubicin—thyroid cancer	0.000125	0.000396	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—SST—thyroid cancer	0.000125	0.00448	CbGpPWpGaD
Venlafaxine—Muscle spasms—Doxorubicin—thyroid cancer	0.000124	0.000394	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—PTCH1—thyroid cancer	0.000124	0.00445	CbGpPWpGaD
Venlafaxine—Palpitations—Epirubicin—thyroid cancer	0.000123	0.000391	CcSEcCtD
Venlafaxine—CYP2D6—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000123	0.00442	CbGpPWpGaD
Venlafaxine—Loss of consciousness—Epirubicin—thyroid cancer	0.000123	0.000389	CcSEcCtD
Venlafaxine—Cough—Epirubicin—thyroid cancer	0.000122	0.000386	CcSEcCtD
Venlafaxine—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000122	0.00438	CbGpPWpGaD
Venlafaxine—Vision blurred—Doxorubicin—thyroid cancer	0.000122	0.000386	CcSEcCtD
Venlafaxine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000121	0.00436	CbGpPWpGaD
Venlafaxine—Convulsion—Epirubicin—thyroid cancer	0.000121	0.000384	CcSEcCtD
Venlafaxine—Hypertension—Epirubicin—thyroid cancer	0.000121	0.000382	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—CALCA—thyroid cancer	0.00012	0.00432	CbGpPWpGaD
Venlafaxine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.00012	0.00038	CcSEcCtD
Venlafaxine—Anaemia—Doxorubicin—thyroid cancer	0.000119	0.000379	CcSEcCtD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000119	0.00428	CbGpPWpGaD
Venlafaxine—Chest pain—Epirubicin—thyroid cancer	0.000119	0.000377	CcSEcCtD
Venlafaxine—Myalgia—Epirubicin—thyroid cancer	0.000119	0.000377	CcSEcCtD
Venlafaxine—Arthralgia—Epirubicin—thyroid cancer	0.000119	0.000377	CcSEcCtD
Venlafaxine—Agitation—Doxorubicin—thyroid cancer	0.000119	0.000377	CcSEcCtD
Venlafaxine—Anxiety—Epirubicin—thyroid cancer	0.000118	0.000376	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—TCF7L1—thyroid cancer	0.000118	0.00423	CbGpPWpGaD
Venlafaxine—Discomfort—Epirubicin—thyroid cancer	0.000117	0.000373	CcSEcCtD
Venlafaxine—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.000117	0.00421	CbGpPWpGaD
Venlafaxine—Malaise—Doxorubicin—thyroid cancer	0.000117	0.00037	CcSEcCtD
Venlafaxine—Dry mouth—Epirubicin—thyroid cancer	0.000116	0.000369	CcSEcCtD
Venlafaxine—Vertigo—Doxorubicin—thyroid cancer	0.000116	0.000368	CcSEcCtD
Venlafaxine—Syncope—Doxorubicin—thyroid cancer	0.000116	0.000367	CcSEcCtD
Venlafaxine—Leukopenia—Doxorubicin—thyroid cancer	0.000116	0.000367	CcSEcCtD
Venlafaxine—ABCG2—Fluoropyrimidine Activity—TP53—thyroid cancer	0.000115	0.00414	CbGpPWpGaD
Venlafaxine—Confusional state—Epirubicin—thyroid cancer	0.000115	0.000364	CcSEcCtD
Venlafaxine—Palpitations—Doxorubicin—thyroid cancer	0.000114	0.000362	CcSEcCtD
Venlafaxine—Anaphylactic shock—Epirubicin—thyroid cancer	0.000114	0.000361	CcSEcCtD
Venlafaxine—Oedema—Epirubicin—thyroid cancer	0.000114	0.000361	CcSEcCtD
Venlafaxine—Loss of consciousness—Doxorubicin—thyroid cancer	0.000114	0.00036	CcSEcCtD
Venlafaxine—Infection—Epirubicin—thyroid cancer	0.000113	0.000359	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—SST—thyroid cancer	0.000113	0.00407	CbGpPWpGaD
Venlafaxine—Cough—Doxorubicin—thyroid cancer	0.000113	0.000358	CcSEcCtD
Venlafaxine—Shock—Epirubicin—thyroid cancer	0.000112	0.000356	CcSEcCtD
Venlafaxine—Convulsion—Doxorubicin—thyroid cancer	0.000112	0.000355	CcSEcCtD
Venlafaxine—Thrombocytopenia—Epirubicin—thyroid cancer	0.000112	0.000354	CcSEcCtD
Venlafaxine—Hypertension—Doxorubicin—thyroid cancer	0.000112	0.000354	CcSEcCtD
Venlafaxine—SLC6A3—NRF2 pathway—NRG1—thyroid cancer	0.000111	0.004	CbGpPWpGaD
Venlafaxine—Tachycardia—Epirubicin—thyroid cancer	0.000111	0.000353	CcSEcCtD
Venlafaxine—Hyperhidrosis—Epirubicin—thyroid cancer	0.00011	0.000349	CcSEcCtD
Venlafaxine—Arthralgia—Doxorubicin—thyroid cancer	0.00011	0.000349	CcSEcCtD
Venlafaxine—Myalgia—Doxorubicin—thyroid cancer	0.00011	0.000349	CcSEcCtD
Venlafaxine—Chest pain—Doxorubicin—thyroid cancer	0.00011	0.000349	CcSEcCtD
Venlafaxine—Anxiety—Doxorubicin—thyroid cancer	0.00011	0.000348	CcSEcCtD
Venlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000109	0.00392	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—CALCA—thyroid cancer	0.000109	0.00392	CbGpPWpGaD
Venlafaxine—Discomfort—Doxorubicin—thyroid cancer	0.000109	0.000345	CcSEcCtD
Venlafaxine—Anorexia—Epirubicin—thyroid cancer	0.000109	0.000345	CcSEcCtD
Venlafaxine—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000108	0.00389	CbGpPWpGaD
Venlafaxine—Dry mouth—Doxorubicin—thyroid cancer	0.000108	0.000341	CcSEcCtD
Venlafaxine—Hypotension—Epirubicin—thyroid cancer	0.000107	0.000338	CcSEcCtD
Venlafaxine—Confusional state—Doxorubicin—thyroid cancer	0.000106	0.000337	CcSEcCtD
Venlafaxine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000105	0.000334	CcSEcCtD
Venlafaxine—Oedema—Doxorubicin—thyroid cancer	0.000105	0.000334	CcSEcCtD
Venlafaxine—Infection—Doxorubicin—thyroid cancer	0.000105	0.000332	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000104	0.000329	CcSEcCtD
Venlafaxine—Shock—Doxorubicin—thyroid cancer	0.000104	0.000329	CcSEcCtD
Venlafaxine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000103	0.000327	CcSEcCtD
Venlafaxine—Insomnia—Epirubicin—thyroid cancer	0.000103	0.000327	CcSEcCtD
Venlafaxine—Tachycardia—Doxorubicin—thyroid cancer	0.000103	0.000326	CcSEcCtD
Venlafaxine—Paraesthesia—Epirubicin—thyroid cancer	0.000102	0.000325	CcSEcCtD
Venlafaxine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000102	0.000323	CcSEcCtD
Venlafaxine—Dyspnoea—Epirubicin—thyroid cancer	0.000102	0.000322	CcSEcCtD
Venlafaxine—Somnolence—Epirubicin—thyroid cancer	0.000101	0.000321	CcSEcCtD
Venlafaxine—Anorexia—Doxorubicin—thyroid cancer	0.000101	0.000319	CcSEcCtD
Venlafaxine—Dyspepsia—Epirubicin—thyroid cancer	0.0001	0.000318	CcSEcCtD
Venlafaxine—CYP2D6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	9.96e-05	0.00358	CbGpPWpGaD
Venlafaxine—Decreased appetite—Epirubicin—thyroid cancer	9.91e-05	0.000314	CcSEcCtD
Venlafaxine—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	9.87e-05	0.00355	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—CDK1—thyroid cancer	9.87e-05	0.00355	CbGpPWpGaD
Venlafaxine—Hypotension—Doxorubicin—thyroid cancer	9.85e-05	0.000312	CcSEcCtD
Venlafaxine—Fatigue—Epirubicin—thyroid cancer	9.83e-05	0.000312	CcSEcCtD
Venlafaxine—Constipation—Epirubicin—thyroid cancer	9.75e-05	0.000309	CcSEcCtD
Venlafaxine—Pain—Epirubicin—thyroid cancer	9.75e-05	0.000309	CcSEcCtD
Venlafaxine—SLC6A3—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	9.66e-05	0.00347	CbGpPWpGaD
Venlafaxine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	9.61e-05	0.000305	CcSEcCtD
Venlafaxine—Insomnia—Doxorubicin—thyroid cancer	9.54e-05	0.000302	CcSEcCtD
Venlafaxine—Paraesthesia—Doxorubicin—thyroid cancer	9.47e-05	0.0003	CcSEcCtD
Venlafaxine—Dyspnoea—Doxorubicin—thyroid cancer	9.4e-05	0.000298	CcSEcCtD
Venlafaxine—Feeling abnormal—Epirubicin—thyroid cancer	9.39e-05	0.000298	CcSEcCtD
Venlafaxine—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	9.38e-05	0.00337	CbGpPWpGaD
Venlafaxine—Somnolence—Doxorubicin—thyroid cancer	9.38e-05	0.000297	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Epirubicin—thyroid cancer	9.32e-05	0.000296	CcSEcCtD
Venlafaxine—Dyspepsia—Doxorubicin—thyroid cancer	9.28e-05	0.000294	CcSEcCtD
Venlafaxine—Decreased appetite—Doxorubicin—thyroid cancer	9.17e-05	0.000291	CcSEcCtD
Venlafaxine—Fatigue—Doxorubicin—thyroid cancer	9.09e-05	0.000288	CcSEcCtD
Venlafaxine—Urticaria—Epirubicin—thyroid cancer	9.05e-05	0.000287	CcSEcCtD
Venlafaxine—Pain—Doxorubicin—thyroid cancer	9.02e-05	0.000286	CcSEcCtD
Venlafaxine—Constipation—Doxorubicin—thyroid cancer	9.02e-05	0.000286	CcSEcCtD
Venlafaxine—Abdominal pain—Epirubicin—thyroid cancer	9.01e-05	0.000286	CcSEcCtD
Venlafaxine—Body temperature increased—Epirubicin—thyroid cancer	9.01e-05	0.000286	CcSEcCtD
Venlafaxine—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	8.97e-05	0.00323	CbGpPWpGaD
Venlafaxine—Feeling abnormal—Doxorubicin—thyroid cancer	8.69e-05	0.000276	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Doxorubicin—thyroid cancer	8.62e-05	0.000273	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—TSHR—thyroid cancer	8.6e-05	0.00309	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PRKAR1A—thyroid cancer	8.46e-05	0.00304	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Epirubicin—thyroid cancer	8.4e-05	0.000266	CcSEcCtD
Venlafaxine—Urticaria—Doxorubicin—thyroid cancer	8.38e-05	0.000266	CcSEcCtD
Venlafaxine—Body temperature increased—Doxorubicin—thyroid cancer	8.34e-05	0.000264	CcSEcCtD
Venlafaxine—Abdominal pain—Doxorubicin—thyroid cancer	8.34e-05	0.000264	CcSEcCtD
Venlafaxine—SLC6A4—Circadian rythm related genes—PPARG—thyroid cancer	8.26e-05	0.00297	CbGpPWpGaD
Venlafaxine—Asthenia—Epirubicin—thyroid cancer	8.18e-05	0.000259	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—MEN1—thyroid cancer	8.09e-05	0.00291	CbGpPWpGaD
Venlafaxine—Pruritus—Epirubicin—thyroid cancer	8.06e-05	0.000256	CcSEcCtD
Venlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	8.03e-05	0.00289	CbGpPWpGaD
Venlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	7.99e-05	0.00287	CbGpPWpGaD
Venlafaxine—Diarrhoea—Epirubicin—thyroid cancer	7.8e-05	0.000247	CcSEcCtD
Venlafaxine—Hypersensitivity—Doxorubicin—thyroid cancer	7.77e-05	0.000246	CcSEcCtD
Venlafaxine—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	7.68e-05	0.00276	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—MINPP1—thyroid cancer	7.63e-05	0.00274	CbGpPWpGaD
Venlafaxine—CYP2B6—Biological oxidations—RXRA—thyroid cancer	7.61e-05	0.00274	CbGpPWpGaD
Venlafaxine—Asthenia—Doxorubicin—thyroid cancer	7.57e-05	0.00024	CcSEcCtD
Venlafaxine—Dizziness—Epirubicin—thyroid cancer	7.54e-05	0.000239	CcSEcCtD
Venlafaxine—Pruritus—Doxorubicin—thyroid cancer	7.46e-05	0.000237	CcSEcCtD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—CP—thyroid cancer	7.4e-05	0.00266	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—TPR—thyroid cancer	7.4e-05	0.00266	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PTCH1—thyroid cancer	7.31e-05	0.00263	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	7.28e-05	0.00262	CbGpPWpGaD
Venlafaxine—Vomiting—Epirubicin—thyroid cancer	7.25e-05	0.00023	CcSEcCtD
Venlafaxine—Diarrhoea—Doxorubicin—thyroid cancer	7.22e-05	0.000229	CcSEcCtD
Venlafaxine—Rash—Epirubicin—thyroid cancer	7.19e-05	0.000228	CcSEcCtD
Venlafaxine—Dermatitis—Epirubicin—thyroid cancer	7.18e-05	0.000228	CcSEcCtD
Venlafaxine—Headache—Epirubicin—thyroid cancer	7.14e-05	0.000226	CcSEcCtD
Venlafaxine—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	7e-05	0.00252	CbGpPWpGaD
Venlafaxine—Dizziness—Doxorubicin—thyroid cancer	6.97e-05	0.000221	CcSEcCtD
Venlafaxine—Nausea—Epirubicin—thyroid cancer	6.77e-05	0.000215	CcSEcCtD
Venlafaxine—Vomiting—Doxorubicin—thyroid cancer	6.71e-05	0.000213	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—SST—thyroid cancer	6.69e-05	0.00241	CbGpPWpGaD
Venlafaxine—Rash—Doxorubicin—thyroid cancer	6.65e-05	0.000211	CcSEcCtD
Venlafaxine—Dermatitis—Doxorubicin—thyroid cancer	6.64e-05	0.000211	CcSEcCtD
Venlafaxine—Headache—Doxorubicin—thyroid cancer	6.61e-05	0.00021	CcSEcCtD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—TPR—thyroid cancer	6.56e-05	0.00236	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—CP—thyroid cancer	6.56e-05	0.00236	CbGpPWpGaD
Venlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	6.51e-05	0.00234	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—NDUFA13—thyroid cancer	6.49e-05	0.00233	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	6.45e-05	0.00232	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CALCA—thyroid cancer	6.44e-05	0.00232	CbGpPWpGaD
Venlafaxine—Nausea—Doxorubicin—thyroid cancer	6.26e-05	0.000199	CcSEcCtD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—BRAF—thyroid cancer	6.16e-05	0.00221	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	6.11e-05	0.0022	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CHST14—thyroid cancer	6.1e-05	0.00219	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—CP—thyroid cancer	6.03e-05	0.00217	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—TPR—thyroid cancer	6.03e-05	0.00217	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	5.93e-05	0.00213	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CDK1—thyroid cancer	5.83e-05	0.0021	CbGpPWpGaD
Venlafaxine—CYP2C19—Biological oxidations—RXRA—thyroid cancer	5.75e-05	0.00207	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—PTEN—thyroid cancer	5.67e-05	0.00204	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—MINPP1—thyroid cancer	5.59e-05	0.00201	CbGpPWpGaD
Venlafaxine—ABCG2—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	5.58e-05	0.00201	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	5.58e-05	0.00201	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.54e-05	0.00199	CbGpPWpGaD
Venlafaxine—CYP2D6—Biological oxidations—RXRA—thyroid cancer	5.29e-05	0.0019	CbGpPWpGaD
Venlafaxine—CYP2C9—Biological oxidations—RXRA—thyroid cancer	5.24e-05	0.00189	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	5.16e-05	0.00186	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—HPGD—thyroid cancer	4.92e-05	0.00177	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	4.91e-05	0.00177	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—NDUFA13—thyroid cancer	4.75e-05	0.00171	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—BRAF—thyroid cancer	4.72e-05	0.0017	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—NRG1—thyroid cancer	4.68e-05	0.00168	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.65e-05	0.00167	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	4.51e-05	0.00162	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CHST14—thyroid cancer	4.47e-05	0.00161	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—MINPP1—thyroid cancer	4.23e-05	0.00152	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—TERT—thyroid cancer	4.2e-05	0.00151	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—MINPP1—thyroid cancer	4.12e-05	0.00148	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.12e-05	0.00148	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—HIF1A—thyroid cancer	4.02e-05	0.00144	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—MINPP1—thyroid cancer	3.89e-05	0.0014	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—TP53—thyroid cancer	3.87e-05	0.00139	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—MINPP1—thyroid cancer	3.85e-05	0.00139	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.79e-05	0.00136	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—HPGD—thyroid cancer	3.6e-05	0.0013	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—NDUFA13—thyroid cancer	3.59e-05	0.00129	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—NRAS—thyroid cancer	3.54e-05	0.00127	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—NDUFA13—thyroid cancer	3.51e-05	0.00126	CbGpPWpGaD
Venlafaxine—CYP3A4—Biological oxidations—RXRA—thyroid cancer	3.46e-05	0.00124	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CHST14—thyroid cancer	3.38e-05	0.00121	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—BRAF—thyroid cancer	3.33e-05	0.0012	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—NDUFA13—thyroid cancer	3.3e-05	0.00119	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CHST14—thyroid cancer	3.3e-05	0.00119	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—NDUFA13—thyroid cancer	3.28e-05	0.00118	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	3.26e-05	0.00117	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	3.26e-05	0.00117	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	3.21e-05	0.00115	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CHST14—thyroid cancer	3.11e-05	0.00112	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CHST14—thyroid cancer	3.08e-05	0.00111	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—KRAS—thyroid cancer	3.05e-05	0.0011	CbGpPWpGaD
Venlafaxine—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	3.02e-05	0.00108	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—HRAS—thyroid cancer	2.83e-05	0.00102	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—TPR—thyroid cancer	2.82e-05	0.00102	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PRKAR1A—thyroid cancer	2.78e-05	0.000999	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—HPGD—thyroid cancer	2.72e-05	0.000979	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—HPGD—thyroid cancer	2.66e-05	0.000956	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—HRAS—thyroid cancer	2.59e-05	0.000931	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	2.56e-05	0.000922	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—MINPP1—thyroid cancer	2.54e-05	0.000914	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—AKT1—thyroid cancer	2.52e-05	0.000905	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—HPGD—thyroid cancer	2.5e-05	0.000901	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—HPGD—thyroid cancer	2.48e-05	0.000893	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.44e-05	0.000877	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CCND1—thyroid cancer	2.43e-05	0.000873	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PTEN—thyroid cancer	2.34e-05	0.000843	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	2.32e-05	0.000833	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—AKT1—thyroid cancer	2.29e-05	0.000822	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	2.24e-05	0.000804	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.21e-05	0.000794	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—HRAS—thyroid cancer	2.17e-05	0.00078	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—NDUFA13—thyroid cancer	2.16e-05	0.000777	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—SLC5A5—thyroid cancer	2.11e-05	0.00076	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—NRAS—thyroid cancer	2.09e-05	0.000752	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—TPR—thyroid cancer	2.07e-05	0.000744	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.05e-05	0.000737	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	2.04e-05	0.000732	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CHST14—thyroid cancer	2.03e-05	0.000731	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.01e-05	0.000724	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—KRAS—thyroid cancer	1.8e-05	0.000647	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—RXRA—thyroid cancer	1.78e-05	0.000639	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.72e-05	0.000618	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—HPGD—thyroid cancer	1.64e-05	0.000589	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—TP53—thyroid cancer	1.6e-05	0.000575	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—TPR—thyroid cancer	1.56e-05	0.000562	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—SLC5A5—thyroid cancer	1.55e-05	0.000557	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	1.54e-05	0.000553	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—HRAS—thyroid cancer	1.53e-05	0.00055	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—TPR—thyroid cancer	1.53e-05	0.000549	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.53e-05	0.000549	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PRKAR1A—thyroid cancer	1.5e-05	0.00054	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—TPR—thyroid cancer	1.44e-05	0.000517	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—TPR—thyroid cancer	1.43e-05	0.000513	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	1.42e-05	0.000509	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.4e-05	0.000505	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.39e-05	0.000502	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—AKT1—thyroid cancer	1.35e-05	0.000486	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—RXRA—thyroid cancer	1.3e-05	0.000468	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.29e-05	0.000463	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.27e-05	0.000457	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—SLC5A5—thyroid cancer	1.17e-05	0.000421	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—SLC5A5—thyroid cancer	1.14e-05	0.000411	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PPARG—thyroid cancer	1.12e-05	0.000403	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.1e-05	0.000395	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—SLC5A5—thyroid cancer	1.08e-05	0.000387	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—SLC5A5—thyroid cancer	1.07e-05	0.000384	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1e-05	0.00036	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—RXRA—thyroid cancer	9.84e-06	0.000354	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—RXRA—thyroid cancer	9.6e-06	0.000345	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.57e-06	0.000344	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—TPR—thyroid cancer	9.4e-06	0.000338	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	9.25e-06	0.000333	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—RXRA—thyroid cancer	9.05e-06	0.000325	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—RXRA—thyroid cancer	8.97e-06	0.000323	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PTGS2—thyroid cancer	8.82e-06	0.000317	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.72e-06	0.000314	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PPARG—thyroid cancer	8.22e-06	0.000296	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PTEN—thyroid cancer	7.69e-06	0.000277	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	7.04e-06	0.000253	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PTGS2—thyroid cancer	6.47e-06	0.000233	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PPARG—thyroid cancer	6.21e-06	0.000223	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PPARG—thyroid cancer	6.06e-06	0.000218	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—RXRA—thyroid cancer	5.92e-06	0.000213	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PPARG—thyroid cancer	5.71e-06	0.000205	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PPARG—thyroid cancer	5.66e-06	0.000204	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PTEN—thyroid cancer	5.64e-06	0.000203	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PTGS2—thyroid cancer	4.89e-06	0.000176	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PTGS2—thyroid cancer	4.77e-06	0.000171	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PTGS2—thyroid cancer	4.49e-06	0.000162	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PTGS2—thyroid cancer	4.45e-06	0.00016	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—AKT1—thyroid cancer	4.43e-06	0.000159	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PTEN—thyroid cancer	4.26e-06	0.000153	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PTEN—thyroid cancer	4.16e-06	0.00015	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PTEN—thyroid cancer	3.92e-06	0.000141	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PTEN—thyroid cancer	3.88e-06	0.00014	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PPARG—thyroid cancer	3.73e-06	0.000134	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—AKT1—thyroid cancer	3.25e-06	0.000117	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PTGS2—thyroid cancer	2.94e-06	0.000106	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PTEN—thyroid cancer	2.56e-06	9.21e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—AKT1—thyroid cancer	2.46e-06	8.83e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—AKT1—thyroid cancer	2.4e-06	8.62e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—AKT1—thyroid cancer	2.26e-06	8.12e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—AKT1—thyroid cancer	2.24e-06	8.05e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—AKT1—thyroid cancer	1.48e-06	5.31e-05	CbGpPWpGaD
